专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

GB9908084D0 Speed hazard warning system 未知
公开(公告)号：GB9908084D0
公开(公告)日：1999-06-02
申请号：GB9908084
申请日：1999-04-12
申请人： BAMBOROUGH PAUL

2. 发明专利

GB2295482B Video editing systems 未知
公开(公告)号：GB2295482B
公开(公告)日：1997-12-10
申请号：GB9525301
申请日：1994-06-10
申请人： LIGHTWORKS EDITING SYSTEMS LTD , BAMBOROUGH PAUL
发明人： BAMBOROUGH PAUL
IPC分类号： G11B27/034 , G11B27/36 , H04N5/262 , G11B27/031 , H04N1/387 , H04N1/41 , H04N7/24

3. 发明专利

GB2295482A Video editing systems 未知
公开(公告)号：GB2295482A
公开(公告)日：1996-05-29
申请号：GB9525301
申请日：1994-06-10
申请人： LIGHTWORKS EDITING SYSTEMS LTD , BAMBOROUGH PAUL
发明人： BAMBOROUGH PAUL
IPC分类号： G11B27/034 , G11B27/36 , H04N5/262 , G11B27/031 , H04N7/24
摘要： A system for editing video material comprises: (a) first digital data handling means for receiving and storing a sequence of image frames of relatively high quality; (b) means for converting the sequence of image frames into a corresponding sequence of image frames of relatively low quality; (c) second digital data handling means for receiving and storing the science of relatively low quality image frames; (d) operator input means associated with the second data handling means to enable manipulation of the sequence of relatively low quality image frames for edit decisions to be made; (e) communication means connected between the first and second data handling means, for communicating to the first data handling means edit decisions after manipulation of the frames in the second data handling means, substantially as such decisions are made; (f) means within the first data handling means for processing a first edit decision, and for manipulating the relatively high quality image frames accordingly, whilst the operator manipulates the relatively low quality frames in the second data handling means to make a second edit decision for communications to the first data handling means; and (g) means within the first data handling means for producing an output sequence of relatively high quality image frames in accordance with the first, second and any subsequent edit decisions communicated from the second data handling means.

4. 发明专利

GB9525301D0 Video editing systems 未知
公开(公告)号：GB9525301D0
公开(公告)日：1996-02-21
申请号：GB9525301
申请日：1994-06-10
申请人： LIGHTWORKS EDITING SYSTEMS LTD , BAMBOROUGH PAUL
IPC分类号： G11B27/034 , G11B27/36 , H04N5/262

5. 发明申请

WO2004010995A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS 审中-公开
标题翻译：用于治疗IA的P38激酶抑制剂的FUSED HETEROARYL DERIVATIVES 湿疹病毒
公开(公告)号：WO2004010995A1
公开(公告)日：2004-02-05
申请号：PCT/GB2003/003316
申请日：2003-07-30
申请人： SMITHKLINE BEECHAM CORPORATION , ANGELL, Richard, Martyn , BALDWIN, Ian, Robert , BAMBOROUGH, Paul , DEBOECK, Nigel, Marc , LONGSTAFF, Timothy , SWANSON, Stephen
发明人： ANGELL, Richard, Martyn , BALDWIN, Ian, Robert , BAMBOROUGH, Paul , DEBOECK, Nigel, Marc , LONGSTAFF, Timothy , SWANSON, Stephen
IPC分类号： A61K31/416
CPC分类号： C07D413/14 , C07D231/56 , C07D261/20 , C07D277/82 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/04 , C07D413/12 , C07D417/12 , C07D417/14
摘要： Compounds of formula (I): wherein A is a 5-membered heteroaryl ring are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38, such as rheumatoid arthritis.
摘要翻译：式（I）化合物：其中A是5元杂芳基环是p38激酶的抑制剂，并且可用于治疗由p38激酶活性介导的或由p38活性产生的细胞因子介导的病状或疾病状态，例如类风湿关节炎。

6. 发明申请

WO2003032987A1 2'-METHYL-5'-(1,3,4-OXADIAZOL-2-YL)-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS 审中-公开
标题翻译： 2'-甲基-5'-1,3,4-OXADIAZOL-2-YL-1,1'-联苯-4-羧酰胺衍生物及其作为P38激酶抑制剂的用途
公开(公告)号：WO2003032987A1
公开(公告)日：2003-04-24
申请号：PCT/EP2002/011575
申请日：2002-10-16
申请人： GLAXO GROUP LIMITED , ANGELL, Richard, Martyn , BAMBOROUGH, Paul , COCKERILL, George, Stuart , SMITH, Kathryn, Jane , WALKER, Ann, Louise
发明人： ANGELL, Richard, Martyn , BAMBOROUGH, Paul , COCKERILL, George, Stuart , SMITH, Kathryn, Jane , WALKER, Ann, Louise
IPC分类号： A61K31/4245
CPC分类号： C07D271/10
摘要： Compounds of formula (I) wherein when m is 0 to 4 R 1 is selected from C 1-6 alkyl, C 3-7 cycloalkyl, C 2-6 alkenyl, -SO 2 NR 4 R 5 , -CONR 4 R 5 and -COOR 4 ; and when m is 2 to 4 R 1 is additionally selected from C 1-6 alkoxy, hydroxy, NR 4 R 5 , -NR 4 SO 2 R 5 , -NR 4 SOR 5 , -NR 4 COR 5 , and -NR 4 CONR 4 R 5 ; R 2 is selected from hydrogen, C 1-6 alkyl and -(CH 2 ) n -C 3-7 cycloalkyl; R 3 is the group R 6 is selected from hydrogen and C 1-4 alkyl; U is selected from methyl and halogen; X and Y are each selected independently from hydrogen, methyl and halogen; m is selected from 0, 1, 2, 3 and 4 wherein each carbon atom of the resulting carbon chain may be optionally substituted with one or two groups selected independently from C 1-6 alkyl; n is selected from 0, 1, 2 and 3; r is selected from 0, 1 and 2; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
摘要翻译：当m为0至4个R 11时，式（I）的化合物选自C 1-6烷基，C 3-7环烷基，C 2-6烯基，-SO 2 S 2，NR 4，R 5，-CONR 4， / sp> R＆lt; 5＆gt;和-COOR 4。当m为2至4时，另外选自C 1-6烷氧基，羟基，NR 4 R 5， / sp>，-NR 4 S S S S sp 3，-NR 4，R 5，R 6，R 6和R 4各自独立地为氢， SP>; R 6选自氢，C 1-6烷基和 - （CH 2）n - （CH 3）n - sb> 3-7环烷基; R 6是选自氢和C 1-4烷基的基团R 6。 U选自甲基和卤素; X和Y各自独立地选自氢，甲基和卤素; m选自0,1,2,3和4，其中所得碳链的每个碳原子可以任选被一个或两个独立地选自C 1-6烷基的基团取代; n选自0,1,2和3; r选自0,1和2; 或其药学上可接受的盐或溶剂化物，以及它们作为药物的用途，特别是作为p38激酶抑制剂。

7. 发明申请

WO2003032971A1 5’-ACYLAMINO-1,1’-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS 审中-公开
标题翻译： 5'-ACYLAMINO-1,1'-联苯-4-羧酰胺衍生物及其作为P38激酶抑制剂的用途
公开(公告)号：WO2003032971A1
公开(公告)日：2003-04-24
申请号：PCT/EP2002/011576
申请日：2002-10-16
申请人： GLAXO GROUP LIMITED , ANGELL, Richard, Martyn , ASTON, Nicola, Mary , BAMBOROUGH, Paul , BAMFORD, Mark, James , COCKERILL, George, Stuart , FLACK, Stephen, Sean , LAINE, Dramane, Ibrahim , MERRICK, Suzanne, Joy , SMITH, Kathryn, Jane , WALKER, Ann, Louise
发明人： ANGELL, Richard, Martyn , ASTON, Nicola, Mary , BAMBOROUGH, Paul , BAMFORD, Mark, James , COCKERILL, George, Stuart , FLACK, Stephen, Sean , LAINE, Dramane, Ibrahim , MERRICK, Suzanne, Joy , SMITH, Kathryn, Jane , WALKER, Ann, Louise
IPC分类号： A61K31/166
CPC分类号： C07D207/27 , C07C237/42 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07D207/327 , C07D213/81 , C07D213/82 , C07D215/50 , C07D239/28 , C07D239/42 , C07D241/24 , C07D241/26 , C07D261/18 , C07D277/56 , C07D307/24 , C07D307/54 , C07D307/68 , C07D309/08 , C07D333/38 , C07D401/04 , C07D405/04 , C07D409/04 , C07D417/04
摘要： Compounds of formula (I): wherein R 3 is the group -NH-CO-R 6 ; or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
摘要翻译：式（I）化合物：其中R 3是基团-NH-CO-R 6; 或其药学上可接受的盐或溶剂化物，以及它们作为药物的用途，特别是作为p38激酶抑制剂。

8. 发明申请

WO2005075465A1 BENZIMIDAZOL SUBSTITUTED THIOPENE DERIVATIVES WITH ATCTIVITY ON IKK3 审中-公开
标题翻译：在IKK3上具有诱发作用的苯并咪唑取代的噻吩衍生物
公开(公告)号：WO2005075465A1
公开(公告)日：2005-08-18
申请号：PCT/EP2005/001432
申请日：2005-02-07
申请人： GLAXO GROUP LIMITED , BAMBOROUGH, Paul , MOREY, James, Vaughan
发明人： BAMBOROUGH, Paul , MOREY, James, Vaughan
IPC分类号： C07D409/04
CPC分类号： C07D409/04 , C07D409/14
摘要： A compound of Formula (I): and compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such benzimidazole derivatives are potentially useful in the treatment of diseases associated with inappropriate I-kappa-B kinase-3 (IKK3) (also known as I-kappa-B kinase epsilon (IKKε) or inducible I-kappa B kinase (IKKi)) activity.
摘要翻译：式（I）的化合物及其组合物和药物，以及制备和使用这些化合物，组合物和药物的方法。这种苯并咪唑衍生物可用于治疗与不适当的I-κB激酶-3（IKK3）（也称为I-kappa-B激酶ε（IKKε）或诱导型I-κB激酶（IKKi））相关的疾病）活动。

9. 发明申请

WO2004089874A1 BIPHENYL CARBOXYLIC AMIDE P38 KINASE INHIBITORS 审中-公开
公开(公告)号：WO2004089874A1
公开(公告)日：2004-10-21
申请号：PCT/EP2004/003774
申请日：2004-04-07
申请人： SMITHKLINE BEECHAM CORPORATION , ASTON, Nicola, Mary , BAMBOROUGH, Paul , JONES, Katherine, Louise , PATEL, Vipulkumar, Kantibhai , SWANSON, Stephen , WALKER, Ann, Louise
发明人： ASTON, Nicola, Mary , BAMBOROUGH, Paul , JONES, Katherine, Louise , PATEL, Vipulkumar, Kantibhai , SWANSON, Stephen , WALKER, Ann, Louise
IPC分类号： C07C233/65
CPC分类号： C07D271/06 , C07C235/42 , C07C235/46 , C07C237/30 , C07C237/42 , C07C275/42 , C07C311/04 , C07C311/15 , C07C2601/02 , C07D295/088 , C07D295/185
摘要： Compounds of formula (I) or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
摘要翻译：式（I）化合物或其药学上可接受的衍生物及其作为药物的用途，特别是作为p38激酶抑制剂。

10. 发明申请

WO2003032980A1 5'-CARBAMOYL-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS 审中-公开
标题翻译： 5'-CARBAMOYL-1,1'-联苯-4-羧酰胺衍生物及其作为P38激酶抑制剂的用途
公开(公告)号：WO2003032980A1
公开(公告)日：2003-04-24
申请号：PCT/EP2002/011573
申请日：2002-10-16
申请人： GLAXO GROUP LIMITED , ANGELL, Richard, Martyn , ASTON, Nicola, Mary , BAMBOROUGH, Paul , BAMFORD, Mark, James , COCKERILL, George, Stuart , MERRICK, Suzanne, Joy , WALKER, Ann, Louise
发明人： ANGELL, Richard, Martyn , ASTON, Nicola, Mary , BAMBOROUGH, Paul , BAMFORD, Mark, James , COCKERILL, George, Stuart , MERRICK, Suzanne, Joy , WALKER, Ann, Louise
IPC分类号： A61K31/40
CPC分类号： C07D295/182 , C07D211/26 , C07D231/12 , C07D233/56 , C07D249/08 , C07D277/28 , C07D295/13 , C07D295/135 , C07D307/14 , C07D307/52
摘要： Compounds of formula (I): wherein X is a bond or a phenyl group which may be optionally substituted; R 1 is selected from an optionally substituted five- to seven-membered heterocyclic ring, an optionally substituted five- to seven-membered heteroaryl ring and an optionally substituted fused bicyclic ring; R 2 is selected from hydrogen, C 1-6 alkyl and -(CH 2 ) p -C 3-7 cycloalkyl; or when X is a bond and m and n are both zero R 1 and R 2 , together with the nitrogen atom to which they are bound, form a five- to six-membered heterocyclic ring optionally containing one additional heteroatom selected from oxygen and nitrogen, which can be optionally substituted by C 1-4 alkyl; R 3 is the group -CO-NH-(CH 2 ) q -R 4 ; U is selected from methyl and halogen; W is selected from methyl and chlorine; V and Y are each selected independently from hydrogen, methyl and halogen; Z is selected from -O- and a bond; m and n are independently selected from 0, 1 and 2, wherein each carbon atom of the resulting carbon chain may be optionally substituted with up to two groups selected independently from C 1-6 alkyl, and the sum of m+ n is from 0 to 4; p is selected from 0 and 1; q and s are selected from 0, 1 and 2; r is selected from 0, 1 and 2; or pharmaceutically acceptable salts or solvated thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
摘要翻译：式（I）的化合物：其中X是可以任意取代的键或苯基; R 6选自任选取代的五至七元杂环，任选取代的五元至七元杂芳基环和任选取代的稠合双环; R 2选自氢，C 1 -C 6烷基和 - （CH 2 b）2 s C 3 -C 7 - 环烷基; 或者当X是键并且m和n均为0时，与其结合的氮原子一起形成5至6个碳原子任选地含有一个选自氧和氮的另外的杂原子，其可以任选被C 1-4烷基取代; R 3是基团-CO-NH-（CH 2）2，其中R 1和R 2各自独立地为氢。 U选自甲基和卤素; W选自甲基和氯; V和Y各自独立地选自氢，甲基和卤素; Z选自-O-和键; m和n独立地选自0,1和2，其中所得碳链的每个碳原子可以任选被至多两个独立地选自C 1-6烷基的基团取代，并且总和 m + n为0〜4; p选自0和1; q和s选自0,1和2; r选自0,1和2; 或其药学上可接受的盐或溶剂合物，以及它们作为药物的用途，特别是作为p38激酶抑制剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式